$TAVI Balance Sheet | Understand Stock

$TAVI

$10.85 +$0.00 (0.0%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Assets
Current assets
Cash
Cash and cash equivalents
Prepaid expenses
Total current assets
Marketable securities held in Trust Account
Total Assets
Current liabilities
Accrued offering costs
Accrued expenses
Advances from related party
Promissory notes – related parties
Total Liabilities
Ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of $10.06 per share
Ordinary shares subject to possible redemption, 4,332,775 and 11,500,000 shares at redemption value of approximately $10.70 and $10.50 per share as of June 30, 2026 and December 31, 2025, respectively
Shareholders’ Deficit
Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 4,420,833 shares issued and outstanding (excluding 4,332,775 and 11,500,000 subject to possible redemption as of June 30, 2026 and December 31, 2025, respectively) as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit

Comments